Top Markets
Coin of the day
Minerva Surgical, Inc. Minerva Surgical, Inc.

Minerva Surgical, Inc.

UTRS
株式のランク #42552
Minerva Surgical, Inc. functions as a commercial-stage medical technology... Minerva Surgical, Inc. functions as a commercial-stage medical technology enterprise, specializing in the creation, production, and distribution of innovative, minimally invasive solutions tailored to address the uterine healthcare needs of women throughout the United States. Their suite of offerings features advanced endometrial ablation systems, including the Minerva ES and Genesys HTA. They also provide the Symphion Tissue Removal System, a sophisticated, minimally invasive device for uterine tissue removal that uniquely integrates bladeless tissue resection, coagulation capabilities, continuous visualization during procedures, and precise intrauterine pressure monitoring. Additionally, the Resectr Tissue Resection Device is a handheld surgical tool engineered for the hysteroscopic removal and diagnostic evaluation of endometrial polyps. These specialized instruments are utilized by obstetrician-gynecologists across a variety of clinical settings, such as hospitals, outpatient ambulatory surgical centers, and private physician practices. The company was founded in 2008 and is headquartered in Santa Clara, California.
株価
$0.0001
最終同期: 2026-08-11
時価総額
$888.00
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 Minerva Surgical, Inc. (UTRS)

カテゴリー

Minerva Surgical, Inc.(UTRS)の利益
2026 時点の利益 TTM: 0
Minerva Surgical, Inc. の最新の財務報告によると、同社の現在の利益は 0 です。2026 年には 0 の利益を上げ、これは 2026 年の利益 0 と 同等 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Minerva Surgical, Inc. の利益の推移(2026 〜 2026)
各年末の利益
利益 変化
提供された日付のデータは十分ではありません。
同業他社の利益